Health Condition 1: M100- Idiopathic gout
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: a Patients belong to the age group of 21 - 65 years of irrespective of their sex religion caste. b Patients having the classical features of Vatarakta such as Shula Saruka Shotha Raga Kandu, Vidaha Sparshasahishnutha etc. c Serum Uric Acid level for male more than 7mg per dl and for female more than 6mg per dl. d Patients willing to participate in the trial and give written informed consent.
Exclusion criteria
Exclusion criteria: a Serum Uric Acid more than 10 mg per dl. b Patients already diagnosed with any other inflammatory joint disorders like Rheumatoid arthritis Osteoarthritis. c Patients suffering from Chronic Renal impairment Chronic Respiratory diseases Hepatic disease etc. d Pregnant and Lactating patients. e Patients taking Steroid therapy more than 6 weeks. f Patients taking any form of medication for Hyperuricemia. g Patients with Uncontrolled diabetes HbA1c nore than 7 As per WHO
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Expected Primary End point is improvement in the serum uric acid from baseline Day 1 after 90 days of intervention.Timepoint: The Expected Primary End point is improvement in the serum uric acid from baseline Day 1 after 90 days of intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| To confirm the collected Yavasa samples meets official API standards ensuring its quality and medicinal authenticity. The Expected secondary outcome is the safety and efficacy of the therapy under investigation. Safety will be assessed based on the adverse events recorded during the study. Timepoint: 3 months | — |
Countries
India
Contacts
Ayurvedic and unani tibbia college